| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |